Stocks
Bristol-Myers (BMY) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 20 118 | 19 221 | 19 366 | 3 168 | 14 545 | 13 776 | ||
| Changes by years, y/y, % | +300% | -4% | +1% | -84% | +359% | +23.6% | |||
Bristol-Myers. EBITDA US GAAP, bln rub
Bristol-Myers. EBITDA US GAAP, changes, %
Bristol-Myers. EBITDA US GAAP, sum by quarters, bln rub
Bristol-Myers (BMY) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 4 477 | 3 287 | 4 587 | 2 194 | 3 708 | 13 776 | |
| Changes by years, y/y, % | -152% | -25% | -4% | -14% | -17% | |||
| Changes by quarters, q/q, % | +75% | -27% | +40% | -52% | +69% | |||
